Rothschild Investment LLC Acquires 79 Shares of Cardinal Health, Inc. (NYSE:CAH)

Rothschild Investment LLC lifted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 10.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 858 shares of the company’s stock after purchasing an additional 79 shares during the period. Rothschild Investment LLC’s holdings in Cardinal Health were worth $101,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Cardinal Health by 35.2% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company’s stock worth $3,871,000 after purchasing an additional 8,471 shares during the period. CHURCHILL MANAGEMENT Corp increased its stake in shares of Cardinal Health by 1.5% in the fourth quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company’s stock worth $28,435,000 after purchasing an additional 3,576 shares during the period. Geode Capital Management LLC increased its stake in Cardinal Health by 0.7% during the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock valued at $633,298,000 after acquiring an additional 42,082 shares during the period. Consolidated Planning Corp increased its stake in Cardinal Health by 40.0% during the fourth quarter. Consolidated Planning Corp now owns 8,926 shares of the company’s stock valued at $1,056,000 after acquiring an additional 2,552 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in Cardinal Health by 2.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock valued at $162,976,000 after acquiring an additional 33,388 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Price Performance

Shares of CAH opened at $127.90 on Wednesday. The company has a market capitalization of $30.90 billion, a P/E ratio of 23.86, a PEG ratio of 1.49 and a beta of 0.63. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $132.84. The business’s 50 day simple moving average is $124.08 and its 200-day simple moving average is $117.72.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.58%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is 37.69%.

Analyst Ratings Changes

Several equities analysts recently issued reports on CAH shares. Wells Fargo & Company boosted their price target on Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. UBS Group boosted their price target on Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a research note on Monday, November 4th. JPMorgan Chase & Co. boosted their price target on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Citigroup boosted their price target on Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. Finally, TD Cowen upgraded Cardinal Health from a “hold” rating to a “buy” rating and upped their price objective for the company from $130.00 to $144.00 in a research note on Wednesday, January 8th. Four investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $138.40.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.